IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells

GLIA

Volumn 63, Issue 5, 2015, Pages 768-779

  Rodgers, Jane M ^a   Robinson, Andrew P ^a   Rosler, Elen S ^b   Lariosa Willingham, Karen ^b   Persons, Rachael E ^c   Dugas, Jason C ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Myelin Repair Foundation   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chemokine; ERK; Inflammation; Interleukin 17; Myelin; Oligodendrocyte

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEOLIPID PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FREUND ADJUVANT; GREEN FLUORESCENT PROTEIN; IL17R PROTEIN, MOUSE; INTERLEUKIN 17 RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT; PLP1 PROTEIN, MOUSE;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TISSUE PREPARATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CEREBELLUM; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CEREBELLUM; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; IN VITRO TECHNIQUES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN PROTEOLIPID PROTEIN; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OLIGODENDROGLIA; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; RECEPTORS, INTERLEUKIN-17; STEM CELLS;

EID: 84925068318     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22783     Document Type: Article

References (36)

1. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
2. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264-278.
3. Chen Y, Kijlstra A, Chen Y, Yang P. 2011. IL-17A stimulates the production of inflammatory mediators via Erk1/2, p38 MAPK, PI3K/Akt, and NF-kappaB pathways in ARPE-19 cells. Mol Vis 17:3072-3077.
4. Chew LJ, King WC, Kennedy A, Gallo V. 2005. Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells. Glia 52:127-143.
5. Codarri L, Gyulveszi G, Tosevski V, Hesske L, Fontana A, Magnenat L, Suter T, Becher B. 2011. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12:560-567.
6. Comerford I, Harata-Lee Y, Bunting MD, Gregor C, Kara EE, McColl SR. 2013. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. Cytokine Growth Factor Rev 24:269-283.
7. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. 1996. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7:354-370.
8. Das Sarma J, Ciric B, Marek R, Sadhukhan S, Caruso ML, Shafagh J, Fitzgerald DC, Shindler KS, Rostami A. 2009. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. J Neuroinflamm 6:14.
9. Elain G, Jeanneau K, Rutkowska A, Mir AK, Dev KK. 2014. The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes. Glia 62:725-735.
10. Fyffe-Maricich SL, Karlo JC, Landreth GE, Miller RH. 2011. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci 31:843-850.
11. Hedegaard CJ, Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH. 2008. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 125:161-169.
12. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237:123-130.
13. Hövelmeyer N, Hao Z, Kranidioti K, Kassiotis G, Buch T, Frommer F, von Hoch L, Kramer D, Minichiello L, Kollias G, Lassmann H, Waisman A. 2005. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol 175:5875-5884.
14. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183:7169-7177.
15. Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H, Liu L, Qian W, Ransohoff RM, Bergmann C, Stohlman S, Tuohy VK, Li X. 2010. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32:414-425.
16. Kang Z, Wang C, Zepp J, Wu L, Sun K, Zhao J, Chandrasekharan U, DiCorleto PE, Trapp BD, Ransohoff RM, Li X. 2013. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells. Nat Neurosci 16:1401-1408.
17. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573.
18. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517.
19. Li Z, Li K, Zhu L, Kan Q, Yan Y, Kumar P, Xu H, Rostami A, Zhang GX. 2013. Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation. BMC Immunol 14:20.
20. Lin W, Harding HP, Ron D, Popko B. 2005. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 169:603-612.
21. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508.
22. Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P. 2001. Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol 49:776-785.
23. McKinnon RD, Piras G, Ida JA, Jr., Dubois-Dalcq M. 1993. A role for TGF-beta in oligodendrocyte differentiation. J Cell Biol 121:1397-1407.
24. Miossec P, Korn T, Kuchroo VK. 2009. Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888-898.
25. Paintlia MK, Paintlia AS, Singh AK, Singh I. 2011. Synergistic activity of interleukin-17 and tumor necrosis factor-alpha enhances oxidative stress-mediated oligodendrocyte apoptosis. J Neurochem 116:508-521.
26. Pang Y, Cai Z, Rhodes PG. 2005. Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J Neurosci Res 80:226-234.
27. Peterson RA. 2012. Regulatory T-cells: Diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 40:186-204.
28. Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G, Valerio A, Spano P. 2004. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 25:301-311.
29. Robinson AP, Rodgers JM, Goings GE, Miller SD. 2014. Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: Clues for MS pathogenesis. PLoS One 9:e107649.
30. Rodgers JM, Miller SD. 2012. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J Biol Med 85:447-468.
31. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, Franklin RJ. 2006. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54:297-303.
32. Szczucinski A, Losy J. 2007. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand 115:137-146.
33. Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M. 2002. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol Cell Neurosci 21:602-615.
34. Vela JM, Molina-Holgado E, Arevalo-Martin A, Almazan G, Guaza C. 2002. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 20:489-502.
35. Vernerey J, Macchi M, Magalon K, Cayre M, Durbec P. 2013. Ciliary neurotrophic factor controls progenitor migration during remyelination in the adult rodent brain. J Neurosci 33:3240-3250.
36. Wolswijk G. 2000. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123(Pt 1):105-115.